CompletedPhase 4NCT01149876
Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots
Studying Hyperpigmentation of the skin
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Molly Wanner, MDMGH
- Intervention
- Nu Skin Product(other)
- Enrollment
- 80 target
- Eligibility
- 25-55 years · FEMALE
- Timeline
- 2010 – 2011
Study locations (1)
- Massachusetts General Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01149876 on ClinicalTrials.govOther trials for Hyperpigmentation of the skin
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT07136766An 18-week Study to Evaluate a Test Product With a Marketed Prescription ProductGood Molecules, LLC
- ACTIVE NOT RECRUITINGNANCT07162623Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects With Facial Dark Spots Such as Pimple Marks, Sunspots, Age Spots and Uneven Skin ToneNovoBliss Research Pvt Ltd
- RECRUITINGNANCT07067879The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip HyperpigmentationChulalongkorn University
- RECRUITINGNANCT06253468Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 OriginsCosmetique Active International
- RECRUITINGNANCT06349447Pilot Study of LED for PIE and PIHYanjun Dan
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07067515Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival HyperpigmentationSuez Canal University
- RECRUITINGNANCT05362929Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of ColorAlbert Einstein College of Medicine